Substrate Ablation Guided by High Density Mapping in Atrial Fibrillation

Last updated: October 3, 2017
Sponsor: Hospital St. Joseph, Marseille, France
Overall Status: Completed

Phase

N/A

Condition

Chest Pain

Arrhythmia

Atrial Fibrillation

Treatment

N/A

Clinical Study ID

NCT02093949
SUBSTRATE-HD
  • Ages 18-85
  • All Genders

Study Summary

To evaluate a new AF Substrate mapping method based on automatic high density CFAE detection with a multipolar catheter (Pentaray) and the " SCI 30-40 " setting of CARTO CFAE algorithm.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient from 18 to 85, with AF* (paroxysmal, and persistent AF) and indication of AFablation (including redos)* *In accordance with the recommendation of European Societyof Cardiology (2010).

Exclusion

Exclusion Criteria:

  • organized atrial activity (Atrial tachycardia or Flutter)

Study Design

Total Participants: 152
Study Start date:
September 01, 2013
Estimated Completion Date:
August 31, 2016

Study Description

This study is observational :

This substrate ablation method is performed routinely in the centers involved in the study so, patients were not assigned by the investigators to undergo a specific procedure because of the study, in all cases patient would have beneficiate from this substrate mapping ablation method.

We assessed procedural and follow up outcomes of this subatrate ablation group and compared them with an historical control group undergoing conventional ablation.

Connect with a study center

  • Hopital Saint Joseph

    Marseille, 13008
    France

    Site Not Available

  • CHU

    Nice,
    France

    Site Not Available

  • Institut Mutualiste de Montsouris

    Paris,
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.